Office of Pharmaceutical Quality (OPQ) Reorganization Webinar

FDA is announcing a webinar on the reorganization of the Center for Drug Evaluation and Research’s (CDER) Office of Pharmaceutical Quality (OPQ). This reorganization was implemented in January and does not result in any direct or immediate changes for external groups, including drug manufacturers.

Timestamps

00:09 – Opening Remarks

01:56 – OPQ Reorganization

27:53 – OPQ Future

36:20 – Closing Remarks

Speakers:

Michael Kopcha, PhD, RPh
Director
Office of Pharmaceutical Quality (OPQ)
Center for Drug Evaluation and Research (CDER)
U.S. Food and Drug Administration (FDA)

Ruth Auguste
Project Manager
Office of Quality Assurance (OQA)
OPQ | CDER | FDA


Learn more at: https://www.fda.gov/drugs/news-events...

-----------------------

FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.

Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2024 Playlist -    • 2024 CDER Small Business and Industry...  
SBIA LinkedIn -   / cder-small-business-and-industry-assistance  
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter -   / fda_drug_info  
Email - [email protected]
Phone - (301) 796-6707 I (866) 405-5367